BSX Boston Scientific Corp
Company Analysis
Latest News
Boston Scientific Bets $1.5B on Heart Tech, Launches $2B Share Buyback
Boston Scientific invested $1.5 billion to acquire an approximately 34% stake in medical technology firm MiRus. The agreement includes an exclusive option to...
🟢 Boston Scientific is trading 4.2% up today as a recovery bounce despite broader healthcare weakness
Boston Scientific is trading 4.2% up today at $44.84, staging a recovery bounce despite a broader decline in the healthcare sector. • There are no fresh...
🔴 Boston Scientific is trading 4.1% down today on reduced growth guidance and segment slowdowns
Boston Scientific is trading 4.1% down at $42.82 as investors react to reduced growth guidance and segment slowdowns. • Management lowered full-year organic...
🟢 BSX extends move to 5.1% up
BSX is trading at $45.25, up 5.1% versus the comparison close of $43.06 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 Boston Scientific Corp is trading 4.3% down today on Fed-driven risk-off sentiment
Boston Scientific Corp is trading 4.3% down at $44.91 as a hawkish Federal Reserve outlook pressures higher-valuation growth names. • The Federal Reserve held...
Boston Scientific Corp Q1 2026 Earnings Preview: What Analysts Expect on April 29, 2026
Analysts expect Boston Scientific to report Q1 2026 revenue of $5.18 billion and adjusted EPS of $0.79, while the stock currently trades near $60.84 against a...
Boston Scientific's first quarter 2026 revenue of $5.2B beats estimates, driven by 13.5% growth in Cardiovascular sales.
Boston Scientific reported first quarter 2026 net sales of $5.203 billion, an increase of 11.6% on a reported basis, and adjusted EPS of $0.80. The results...
Boston Scientific Corp Q1 2026 Earnings Preview: What Analysts Expect on April 22, 2026
Boston Scientific Corp is expected to report Q1 2026 revenue of $5.19 billion and adjusted EPS of $0.80, while its stock currently trades around $61.32 against...